Devia Emerges From Stealth With AI Agents for Pharmaceutical Quality Investigations
AI-generated summary Zurich-based spin-out Devia has emerged from stealth to apply AI agents to pharmaceutical quality investigations and deviation management. The company states that its platform structures initial reports, gathers evidence, drafts root-cause analyses, and prepares corrective actions for human review.